The new potential coronavirus vaccine of Oxford University and Astra Zeneca has been shown to produce a strong immune response, according to early-stage clinical trials. Results were published on July 20, 2020 in the British medical journal The Lancet. About 1.000 people were involved in the Phase 2 Oxford trials, with about half of the subjects receiving the experimental vaccine.
Editorial use only Contact your sales representative for commercial and promotional uses.License this clip
More footage filed by NurPhoto videographers.